Michael J Strong
Strong, Michael J.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 31381323 (Personal)
Permalink: http://viaf.org/viaf/31381323
Preferred Forms
-
100 0 _
‡a
Michael J Strong
-
100 1 _
‡a
Strong, Michael J.
-
100 1 _ ‡a Strong, Michael J.
-
100 1 _
‡a
Strong, Michael J.
-
100 1 _
‡a
Strong, Michael J.
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| Amyotrophic lateral sclerosis and the frontotemporal dementias |
|
| Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. |
|
| Chronic aluminum-induced motor neuron degeneration: clinical, neuropathological and molecular biological aspects |
|
| Cognitive impairment in sporadic ALS: a pathologic continuum underlying a multisystem disorder |
|
| Comparative study of chronic aluminum-induced neurofilamentous aggregates with intracytoplasmic inclusions of amyotrophic lateral sclerosis. |
|
| Creutzfeldt-Jakob disease presenting with visual manifestations |
|
| Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. |
|
| Detection of a novel frameshift mutation and regions with homozygosis within ARHGEF28 gene in familial amyotrophic lateral sclerosis |
|
| Diagnosis of Inclusion |
|
| Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury |
|
| Dose-dependent selective suppression of light (NFL) and medium (NFM) but not heavy (NFH) molecular weight neurofilament mRNA levels in acute aluminum neurotoxicity. |
|
| Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs |
|
| The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases. |
|
| The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). |
|
| Factors correlated with NPPV use in ALS |
|
| The frontotemporal syndromes of ALS. Clinicopathological correlates. |
|
| Genetic analysis of SIGMAR1 as a cause of familial ALS with dementia |
|
| Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene |
|
| Hemiageusia, hemianaesthesia and hemiatrophy of the tongue |
|
| Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans |
|
| Increasing peak expiratory flow time in amyotrophic lateral sclerosis. |
|
| Isolation of fetal mouse motor neurons on discontinuous Percoll density gradients |
|
| Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS |
|
| Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype |
|
| Metabolic changes in human muscle denervation: topical 31P NMR spectroscopy studies |
|
| Methods for estimating numbers of motor units in biceps-brachialis muscles and losses of motor units with aging. |
|
| Microtubule-associated tau protein positive neuronal and glial inclusions in ALS. |
|
| Motor neuron disorders, c2003: |
|
| Multiple cerebral infarcts in patient with Moyamoya disease |
|
| N-butylbenzenesulphonamide, a novel neurotoxic plasticising agent |
|
| NIPPV: prevalence, approach and barriers to use at Canadian ALS centres. |
|
| Nitric oxide synthase expression in cervical spinal cord in sporadic amyotrophic lateral sclerosis. |
|
| NMDA induces NOS 1 translocation to the cell membrane in NGF-differentiated PC 12 cells. |
|
| Novel miR-b2122 regulates several ALS-related RNA-binding proteins. |
|
| The Ontario Neurodegenerative Disease Research Initiative (ONDRI). |
|
| Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy |
|
| Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. |
|
| Phase II/III randomized trial of TCH346 in patients with ALS |
|
| Post-transcriptional control of neurofilaments in development and disease. |
|
| Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. |
|
| Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ |
|
| Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults. |
|
| Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. |
|
| Reversibility of neurofilamentous inclusion formation following repeated sublethal intracisternal inoculums of AlCl3 in New Zealand white rabbits |
|
| RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis |
|
| RNA-binding proteins as molecular links between cancer and neurodegeneration. |
|
| RNA metabolism in ALS: when normal processes become pathological. |
|
| Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord |
|
| Spinal motor neuron neuroaxonal spheroids in chronic aluminum neurotoxicity contain phosphatase-resistant high molecular weight neurofilament (NFH). |
|
| Strategies for Supporting Physician-Scientists in Faculty Roles: A Narrative Review With Key Informant Consultations. |
|
| Synergistic toxicity in an in vivo model of neurodegeneration through the co-expression of human TDP-43M337V and tauT175D protein |
|
| TAU mutations are not a predominant cause of frontotemporal dementia in Canadian patients |
|
| Tau protein aggregation in the frontal and entorhinal cortices as a function of aging. |
|
| Tau protein phosphorylation at Thr175 initiates fibril formation via accessibility of the N-terminal phosphatase-activating domain |
|
| TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS |
|
| The temporal expression of amyloid precursor protein mRNA in vitro in dissociated hippocampal neuron cultures. |
|
| Temporal profiles of neuronal degeneration, glial proliferation, and cell death in hNFL(+/+) and NFL(-/-) mice |
|
| Threonine175, a novel pathological phosphorylation site on tau protein linked to multiple tauopathies |
|
| TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia |
|
| Transient middle cerebral artery occlusion induces microglial priming in the lumbar spinal cord: a novel model of neuroinflammation |
|
| Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci) |
|
| Widespread cerebral haemodynamics disturbances occur early in amyotrophic lateral sclerosis. |
|
| Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment. |
|
